Clinical Trial Update: Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of GS-4321 in healthy participants and individuals with Chronic Hepatitis Delta; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Hepatitis Delta

Drugs mentioned

• GS-4321

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis Delta | Phase 1, Phase 2 | Status: RECRUITING